← back to search

Jing Guo

National University of Singapore · SG
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Chemistry, Apoptosis, In vivo, Histone deacetylase, RNA editing, and RNA.
h-index
citations
1,221
works
13
NIH funding
primary concept
email

Recent publications

People are an organic unity: Gut-lung axis and pneumonia
Heliyon 2024cited by 13position: firstdoi
Organism-wide, cell-type-specific secretome mapping of exercise training in mice
Cell Metabolism 2023cited by 83position: middledoi
A catalog of microbial genes from the bovine rumen unveils a specialized and diverse biomass-degrading environment
GigaScience 2020cited by 102position: middledoi
Recent Advances in Multi-target Drugs Targeting Protein Kinases and Histone Deacetylases in Cancer Therapy
Current Medicinal Chemistry 2020cited by 49position: middledoi
Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells
Cell Death and Disease 2019cited by 486position: middledoi
Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities
European Journal of Medicinal Chemistry 2018cited by 34position: middledoi
A novel harmine derivative, N-(4-(hydroxycarbamoyl)benzyl)-1-(4- methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects
European Journal of Pharmacology 2018cited by 26position: middledoi
Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage
European Journal of Medicinal Chemistry 2017cited by 52position: middledoi
Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells
European Journal of Medicinal Chemistry 2017cited by 47position: middledoi
Design and Synthesis of C3‐Substituted β‐Carboline‐Based Histone Deacetylase Inhibitors with Potent Antitumor Activities
ChemMedChem 2017cited by 34position: middledoi
Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities
MedChemComm 2017cited by 25position: middledoi
ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer
Gastroenterology 2016cited by 204position: middledoi
Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome
Nature Biotechnology 2012cited by 521position: middledoi
DNMT Inhibitors and HDAC Inhibitors Regulate E-Cadherin and Bcl-2 Expression in Endometrial Carcinoma in vitro and in vivo
Chemotherapy 2012cited by 31position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yong Ling · Nantong University7 papers (2017–2020)Yanfu Peng · Sun Yat-sen University Cancer Center4 papers (2017–2018)Lin Luo · University of Alabama at Birmingham4 papers (2017–2018)Weijie Gao · Nantong University3 papers (2017–2020)Jiefei Miao · Nantong University3 papers (2017–2018)Jinhua Tao · Nanjing University of Chinese Medicine2 papers (2017–2018)Xinyang Wang · Tianjin University of Science and Technology2 papers (2017–2017)Jiaying Yang · Nanjing University of Chinese Medicine2 papers (2017–2017)Qiuxing Yang · Nantong University2 papers (2017–2018)Hong Dai · Nantong University2 papers (2017–2017)Peng Zhu · Shandong University2 papers (2017–2018)Biao Xiong · Nantong University2 papers (2017–2020)Qibing Xu · Nantong University2 papers (2017–2017)Shi Chen · Hua Medicine (China)2 papers (2017–2018)Yanan Zhang · Jinan University2 papers (2017–2017)Yanan Zhang · Xiamen University2 papers (2017–2018)Liu Ji · National University of Singapore1 papers (2017–2017)Leilei Chen · National University of Singapore1 papers (2016–2016)Wenwei Zhang · Heilongjiang University of Chinese Medicine1 papers (2012–2012)Kai Wang · Hebei Medical University1 papers (2019–2019)